MARKET

QBIO

QBIO

Q Biomed
EXMKT
0.0001
0.0000
0.00%
Closed 14:48 02/12 EST
OPEN
0.0001
PREV CLOSE
0.0001
HIGH
0.0001
LOW
0.0001
VOLUME
700
TURNOVER
0
52 WEEK HIGH
0.0002
52 WEEK LOW
0.0001
MARKET CAP
14.51K
P/E (TTM)
-0.0015
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QBIO last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at QBIO last week (0126-0130)?
Weekly Report · 02/02 10:23
Weekly Report: what happened at QBIO last week (0119-0123)?
Weekly Report · 01/26 10:23
Weekly Report: what happened at QBIO last week (0112-0116)?
Weekly Report · 01/19 10:29
Weekly Report: what happened at QBIO last week (0105-0109)?
Weekly Report · 01/12 10:28
Weekly Report: what happened at QBIO last week (1229-0102)?
Weekly Report · 01/05 10:22
Weekly Report: what happened at QBIO last week (1222-1226)?
Weekly Report · 12/29/2025 10:21
Weekly Report: what happened at QBIO last week (1215-1219)?
Weekly Report · 12/22/2025 10:21
More
About QBIO
Q BioMed Inc. is a biotech acceleration and commercial stage company. The Company is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The Company’s pipeline products include Strontium89, QBM-001, UTTROSIDE-B, and MAN 01. Strontium89 treats pain from bone metastases caused by multiple primary tumors. Strontium Chloride Sr-89 Injection, USP is indicated for the relief of bone pain in patients with painful skeletal metastases. QBM-001 is designed to alleviate the condition and allow toddlers to actively develop language and speech and avoid life-long speech and intellectual disabilities caused from being non-verbal. UTTROSIDE-B is a potential chemotherapeutic for liver cancer. MAN-01 is for the treatment of primary open-angle glaucoma, wherein it is developing a small molecule in the form of an easy to administer eye drop to reduce intra-ocular eye pressure (IOP), a key risk factor in the progression of glaucoma.

Webull offers Q BioMed Inc stock information, including EXMKT: QBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QBIO stock methods without spending real money on the virtual paper trading platform.